Vivo Bio Tech (BOM:511509) Cyclically Adjusted Book per Share: ₹34.51 (As of Mar. 2026)


BOM:511509 Vivo Bio Tech Ltd BOM:511509
63 GF Score
Price ₹23.57
GF Value ₹29.42
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Vivo Bio Tech Cyclically Adjusted Book per Share?

Vivo Bio Tech BOM:511509 +1.95% 63 Cyclically Adjusted Book per Share is ₹34.51 as of Mar. 2026. GuruFocus rates BOM:511509 with a GF Score™ of 63/100 and a GF Value™ of ₹29.42 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Vivo Bio Tech's adjusted book value per share for the three months ended in Mar. 2026 was ₹41.980. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹34.51 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vivo Bio Tech's average Cyclically Adjusted Book Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-12), Vivo Bio Tech's current stock price is ₹23.57. Vivo Bio Tech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹34.51. Vivo Bio Tech's Cyclically Adjusted PB Ratio of today is 0.68.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vivo Bio Tech was 1.71. The lowest was 0.67. And the median was 1.24.


Vivo Bio Tech  (BOM:511509) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vivo Bio Tech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=23.57/34.51
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vivo Bio Tech was 1.71. The lowest was 0.67. And the median was 1.24.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Vivo Bio Tech Cyclically Adjusted Book per Share Related Terms


Vivo Bio Tech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Vivo Bio Tech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech Cyclically Adjusted Book per Share Chart

Vivo Bio Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 27.68 30.55 34.51

Vivo Bio Tech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.55 0.00 32.84 0.00 34.51

BOM:511509 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Vivo Bio Tech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivo Bio Tech Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's Cyclically Adjusted PB Ratio falls into.


BOM:511509
63GF Score
Vivo Bio Tech Ltd BOM:511509
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivo Bio Tech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vivo Bio Tech's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=41.98/164.2724*164.2724
=41.980

Current CPI (Mar. 2026) = 164.2724.

Vivo Bio Tech Quarterly Data

Book Value per Share CPI Adj_Book
201603 10.760 102.518 17.242
201606 0.000 105.961 0.000
201609 12.447 105.961 19.297
201612 0.000 105.196 0.000
201703 13.448 105.196 21.000
201706 0.000 107.109 0.000
201709 15.102 109.021 22.756
201712 0.000 109.404 0.000
201803 19.600 109.786 29.327
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 22.081 118.202 30.687
201906 0.000 120.880 0.000
201909 24.867 123.175 33.164
201912 0.000 126.235 0.000
202003 25.624 124.705 33.754
202006 0.000 127.000 0.000
202009 28.015 130.118 35.369
202012 0.000 130.889 0.000
202103 31.692 131.771 39.509
202106 0.000 134.084 0.000
202109 32.653 135.847 39.485
202112 0.000 138.161 0.000
202203 33.040 138.822 39.097
202206 0.000 142.347 0.000
202209 33.363 144.661 37.886
202212 0.000 145.763 0.000
202303 34.805 146.865 38.930
202306 0.000 150.280 0.000
202309 35.120 151.492 38.083
202312 0.000 152.924 0.000
202403 36.500 153.035 39.180
202406 0.000 155.789 0.000
202409 40.123 157.882 41.747
202412 0.000 158.323 0.000
202503 45.386 157.552 47.322
202506 0.000 159.755 0.000
202509 43.785 162.289 44.320
202512 0.000 163.281 0.000
202603 41.980 164.272 41.980

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹34.51 mean?
Vivo Bio Tech (BOM:511509) has a Cyclically Adjusted Book per Share of ₹34.51 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vivo Bio Tech and its competitors.
Is Vivo Bio Tech's Cyclically Adjusted Book per Share too high?
Vivo Bio Tech's current Cyclically Adjusted Book per Share is ₹34.51. Overall, Vivo Bio Tech has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Vivo Bio Tech's Cyclically Adjusted Book per Share of ₹34.51 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vivo Bio Tech and its competitors. Vivo Bio Tech's current Cyclically Adjusted Book per Share is ₹34.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹29.42, compared to a current price of ₹23.57 — trading 19.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₹34.51. Vivo Bio Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Cyclically Adjusted Book per Share is ₹34.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?

Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued. The current stock price of ₹23.57 is trading 19.9% below its estimated GF Value™ of ₹29.42. GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.

Key valuation signals for BOM:511509:

  • Cyclically Adjusted Book per Share: ₹34.51
  • GF Value™: ₹29.42 vs. price of ₹23.57 (19.9% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivo Bio Tech Business Description

Address Number 8-2-672/ 5 & 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
63GF Score

Get the complete analysis for BOM:511509

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.57
Price
₹29.42
GF Value